engleski

Evaluation of paraoxonase 1 activity in chronic obstructive pulmonary disease

In the recently published paper we reported on decreased activity of PON1 paraoxonase and/or PON1 arylesterase activities in patients with COPD. There are certain diseases such as psoriasis, chronic renal failure, inflammatory bowel diseases, hypertension, Parkinson’s disease, Alzheimer disease, vascular dementia, chronic liver disease, systemic lupus erythematosus, hyperlipidemia and acute phase response status that might influence paraoxonase activity, and confounding effects might be seen in other syndromes and diseases.

paraoxonase 1; chronic obstructive pulmonary disease; age; gende

nije evidentirano